Our Team - Cure Rare Disease | We bridge the gap between researchers and a cure® through customized medicine, by supporting families and educating the global community.

Rich Horgan

Rich Horgan is the Founder and President of Cure Rare Disease. He has a deep passion for Duchenne Muscular Dystrophy (DMD) and other rare diseases. With a younger brother impacted by the disease, Rich has a strong interest in accelerating promising treatments for the disease. He formed a collaboration with world-class researchers and clinicians to pioneer the rapid development of customized therapies for Duchenne and other rare diseases. Prior to making his foray into biotech, Rich had extensive experience working in new business development at Corning Incorporated where he led the successful launch of a new Willow® Glass product. He also launched a successful car washing business in upstate New York. He holds a BS from Cornell University where he graduated summa cum laude and an MBA from Harvard Business School where he was awarded the Blavatnik Fellowship for Life Science Entrepreneurship.

Dr. Melissa Hunter-Ensor

Dr. Melissa Hunter-Ensor is a board member of Cure Rare Disease. She is also Greenberg Traurig’s Global Patent Prosecution Group. Melissa focuses her practice on the intellectual property and commercial needs of clients in the life science industry, encompassing pharmaceutical, biotechnology, chemical agricultural, diagnostics and medical device companies. Melissa has experience representing clients throughout the business cycle, from start-ups and universities to global pharmaceutical companies, with patent portfolio management and strategic alliances, as well as litigation and pre-litigation strategy. She also assists venture capital firms and other investors in assessing the IP risks of target investments and conducts IP patent and licensing due diligence in connection with life science technology transactions.

Before becoming a lawyer, Melissa earned a Ph.D. in neuroscience from the University of Pennsylvania and her thesis research resulted in a first author paper in Cell. She followed this accomplishment with a four-year post-doctoral fellowship at the Massachusetts Institute of Technology laboratory of Nobel laureate H. Robert Horvitz where she was a Jane Coffin Childs fellow.

Marshall D. (Mark) Smith

Mark joined Occidental Petroleum as Senior Executive Vice President and Chief Financial Officer in August 2014 in preparation for the successful IPO and spin of its subsidiary, California Resources in December 2014. He has over 35 years of progressive experience in all aspects of the energy industry. Previously, Mr. Smith served as Senior Vice President and CFO of Ultra Petroleum from July 2005. Prior to Ultra, he most recently served as Vice President, Upstream Business Development for Constellation Energy and previously served as Vice President, Business Development, and as a member of the management committee, for J.M. Huber Energy. During fourteen years of corporate and investment banking with BMO Capital Markets (formerly Bank of Montreal and affiliates), Mark held advisory roles to a diverse range of energy companies including Texaco, Union Pacific Resources, Oryx, Pennzoil, and Anadarko.

Mr. Smith holds a B.S. degree in Petroleum Engineering from the University of Oklahoma, where he was a distinguished scholar, and an MBA with highest honors from Oklahoma City University. He has also completed executive business development programs at Harvard Business School and Stanford Graduate School of Business.

Mr. Smith was named Best CFO of the Year for 2013 for a Medium Public Company by the Houston Business Journal and Best CFO of the Year for 2017 for a Large Public Company by the San Fernando Valley Business Journal.

Mr. Smith continues to be a passionate supporter and involved with muscular dystrophy initiatives for decades. He first came to know of the inspiring strength and courage of those living with the disease as a young boy, as his cousin was impacted. He admired the courage, determination and grace she exhibited as she faced this debilitating disease. Inspired by her and driven by his desire to help kids and adults with neuromuscular diseases live longer and grow stronger, he is passionate about using his skill set to help fund breakthrough research related to rare diseases.

Kwesi Acquay

Kwesi Acquay is an associate at J.P. Morgan in the Technology Investment Banking Group. He is the founder of the J.P. Morgan Digital Initiative: the first initiative dedicated to digital ecosystems and startup engagement across NY & Boston Investment Banking practices.

In addition to Cure Rare Disease, Kwesi serves on the Board of StEP, an education technology startup in Worcester, MA.

Kwesi graduated magna cum laude with a B.S. in Applied Economics and Management from Cornell University in 2014. He is the recipient of the Richard A. Church ’64 Senior Service Award, awarded by the CALS Alumni Association in recognition of leadership and service to Cornell University. He serves on the Advisory Council for Entrepreneurship at Cornell.

Kwesi remains passionate about innovation and how it can make a difference in the community.

Stephanie Herzog

Stephanie Herzog currently serves as a board member for Cure Rare Disease. Stephanie is the CEO/Founder/Owner of a boutique Home & Commercial Interior Design Firm in Connecticut with proven specialties ranging from interior furnishings to complete custom space builds.

Stephanie has over 15 years experience in designing, team leading, project execution, and completion in the robust space she serves.

Stephanie’s passion for Cure Rare Disease and the research strategies for curing Genetic Disorders was born from the recent DMD diagnosis of her four year old son, Max. Throughout Stephanie’s journey she was fortunate enough to meet Rich Horgan and be introduced to the amazing ground-breaking research and work his team is doing for Muscular Dystrophy and similar rare genetic diseases.

Stephanie also serves on the Branford Arts and Culture Alliance Board in Branford, CT as well as the Board of Governors for the Pine Orchard Yacht & Country Club, chairing the Entertainment Committee.

Karen Morales

Karen Morales spent over 20 years in nationally recognized agencies solving Fortune 500 marketing and advertising challenges before she founded her own company, Marketing Magnet, in 2017. Marketing Magnet provides in-depth agency services focused on efficiency, fun, and fast results for businesses of all sizes.

Karen was also diagnosed with LGMD2b when she was a junior in college. Two decades later, she is a mom, survivor and advocate for those with health challenges. She is eager to bring hope and change to the disease community after spending so much of her time and personal resources on navigating the unpaved medical road of a rare disease.

Sara Cole

Sara Cole currently serves as a board member for Cure Rare Disease. She is currently working at IQVIA as a Life Sciences Strategy Consultant. Prior to that, she completed her MBA in the Health Sector Management Program at Boston University. While there, she spent time working in an operations and finance role within the research and development team at Tesaro. Before coming to Boston, she worked as a Process Technician in research and development for Corning Incorporated. There, she focused on process improvement and new process development for the Chemical Analysis Department. Sara is originally from Corning, NY and attended University at Buffalo, earning a BS in Medicinal Chemistry.

Dr. Naomi Hoyle

Dr. Naomi Hoyle is excited to be part of Cure Rare Disease. This is a group that has patient advocacy as its top priority. With a 12 year old son affected by DMD, we are ready for a cure, now! Personalized medicine is the way to propel this forward and make an opportunity become a reality for all of our boys. Dr. Hoyle has been studying bacteriophage since 2002, first as an undergraduate at the Evergreen State College, and later with the G. Eliava Institute in Tbilisi, Georgia. She has been working as the International Relations Manager at the Eliava Phage Therapy Center for the past 8 years, facilitating treatment of antibiotic resistant infections for patients from more than 70 countries around the world. She obtained her MD from Tbilisi State Medical University and specialized in Pediatric Emergency Medicine completing residency at the TSMU G. Jvania Children’s Hospital in Tbilisi.

She is a founding member of the Eliava Foundation and is also a Scientific Advisor to the Phagebiotics Foundation. She currently lives with her husband Vakho, and three boys in Washington State.

Renata Hoyle Maybruck

Renata Hoyle Maybruck has worked in high-level fundraising for non-profit organizations for the past 20 years and has raised over $30 million to date in leadership roles. She has a strong background in major gifts and capital/comprehensive campaigns, board management and strategic planning.

Renata has a Master of Science degree from the London School of Economics in Anthropology and Development. She currently serves as the Vice-President of her local Women In Business chapter and a Board Member of a local non-profit serving at-risk youth in her community.

Renata has joined the Cure Rare Disease board to elevate awareness and raise funds for the crucial work CRD is doing in honor of her beloved nephew who has Duchenne Muscular Dystrophy and for children across the world who will benefit from the technology advancement. She lives in Washington State with her husband, two children and two bunnies.

Liz Duffy

Liz Duffy is the Director of Alumni Relations at Greenwich Country Day School (GCDS), her alma mater. She received her Bachelor’s degree from Hobart and William Smith Colleges and her Master of Public Administration from NYU. As a Director in the GCDS Development office, Liz manages fundraising efforts across more than 4,000 constituents and implements programming and events for the alumni community. Prior to GCDS, Liz worked at Tiger Foundation in New York City. As Program Officer, she conducted comprehensive research for grant renewals and new grant requests for funding areas including education, employment, youth and families, and criminal justice. She serves on the Associate Board of Waterside School, a PK-5th Grade independent school serving children and families regardless of limitations in income or circumstance. Liz lives in Greenwich, CT with her husband and two children, Quinn (6) and Ned (2). Ned was diagnosed with DMD in July 2019, three weeks before his second birthday. Liz, together with Tim, hope to bring development knowledge to Cure Rare Disease.

Jessica Curran

Jessica Curran is a first-grade teacher at Matthew Paterson Elementary School in Patterson, NY (2005-Present) Before that Jessica was a fourth-grade teacher at Matthew Paterson Elementary School (2004-2005) Prior to that Jessica was a fourth-grade teacher at West Patent Elementary School in Bedford, NY (2001-2003).

In her twenty years of experience as an elementary school teacher Jessica has held positions on multiple elementary school committees such as: site base and safety committee, language arts committee, arts in education committee, elementary principal hiring committee, and Positive Behavior Interventions and Supports in the Classroom (PBIS) committee.

Jessica received her Bachelor of Arts in Elementary Education (K-6) and a Bachelor of Science in Psychology from Keene State College in Keene, NH. She also received her master’s degree in Literacy from Manhattanville College in Purchase, NY. She continues to take graduate courses to build her knowledge and keep up with the everchanging strategies and approaches of teaching young children.

Jessica’s son Conner was diagnosed with Duchenne Muscular Dystrophy in 2015. From that point on she was committed to raising money for all the kids with Duchenne Muscular Dystrophy. Jessica and her husband, Christopher, hosted charitable events that have raised over $800,000.000 for the 501(c)3 Parent Project Muscular Dystrophy.

Kindness Over Muscular Dystrophy, a 501 (c)3 charity was formed by Jessica and her husband in 2019 in order to fund scientific research to cure Duchenne Muscular Dystrophy as well as benevolent assistance and advocacy to those in need.

Jessica has been active in advocacy in her home state of Connecticut, Capitol Hill and the FDA. Working directly with Governor Ned Lamont, Jessica spearheaded a campaign to have the Governor sign a proclamation proclaiming that the state of Connecticut recognizes September 7th as World Duchenne Awareness Day. With that proclamation, Connecticut, became the second state in the nation to recognize World Duchenne Day.

On Capitol Hill, Jessica has advocated for Duchenne appropriations with her respective congressional leaders and Senators. Additionally, Jessica has testified before the FDA in a patient-focused compass meeting as part of the FDA’s Patient-focused Drug Development initiative with members of the CDC, SSA and CMS in attendance.

Jessica has been asked to speak at events led by Parent Project Muscular Dystrophy, Springboard Enterprises, Ask Bio and Pfizer. She participated in a 2020 ACA press conference with Senator Richard Blumenthal where she gave an impact statement on how the protections under the Affordable Care Act are vital for people with complex medical issues. Jessica has also been interviewed by NPR, Pix 11NY, Fox CT, News 12 CT, NBC CT, The Hartford Courant, The Ridgefield Press and The Lewisboro Ledger about her experiences raising a son with Duchenne, participating in a Duchenne gene therapy clinical trial and how the ACA impacts her family.

Staff

Alan H. Beggs, PhD

Scientific Director

Alan H. Beggs PhD. joins Cure Rare Disease as our Scientific Director and is excited about the mission of developing customized therapeutics. Alan is also the Director of the Manton Center for Orphan Disease Research at Boston Children’s Hospital and Sir Edwin & Lady Manton Professor of Pediatrics at Harvard Medical School. Following undergraduate studies at Cornell University, Dr. Beggs obtained his PhD in Human Genetics at Johns Hopkins, with subsequent postdoctoral fellowship training in medical and molecular genetics at Johns Hopkins and Boston Children’s hospitals. Throughout his career, he has used the toolset of human molecular genetics to study normal biology and disease processes in a variety of diseases with a particular focus on congenital myopathies, muscular dystrophies, and related neuromuscular diseases. In this role, and as founding director of The Manton Center, he has led the discovery of numerous new disease genes and has pioneered the development of gene therapy for one such condition, myotubular myopathy. The Manton Center provides resources and a training environment to support research on understudied “orphan diseases” through support of junior faculty with multiyear career development awards, pilot project grants, and access to the Center’s Gene Discovery Core (GDC), which provides genetic and genomic analysis services, and a rich collaborative environment for interactions between clinicians, researchers and bioinformaticians. Dr. Beggs has been a standing and ad hoc member of numerous National Institutes of Health grant committees and reviewer for the Muscular Dystrophy Association, March of Dimes and other national and international medical research foundations. He is a member of multiple scientific advisory boards, and boards of directors for both nonprofit and commercial entities.

Rachel Duncan

Director of Social Media, Digital Marketing

Rachel Duncan is the director of social media and digital marketing for Cure Rare Disease. In addition to handling all of Cure Rare Disease’s social media, marketing materials, and graphic design, Rachel also works on general development in furthering the organization’s efforts. Rachel graduated magna cum laude from the College of Communication at Boston University. She joined the CRD team in May of 2019 and says she has been consistently inspired by the incredible work it does every day. She’s both honored and proud to be part of something so special to her. Say hi to Rachel by DMing Cure Rare Disease on any of our social media accounts!

Sarah Krieger

Director of Community Engagement

We are the Krieger Family from Phoenix AZ. My name is Sarah, my husband is Bryant, and we have 4 kiddos; Hans (7), Otto (6), Fritz (4), Ingrid (18mo). I am a former elementary teacher, who now homeschools our kiddos. Bryant works as a Data Analyst at Truckstop.com.

Our family loves traveling and exploring new places, even if that means our own backyard. In our spare time you can find us outdoors! We love hiking, bike riding, playing all sports, swimming, skateboarding, planting and gardening, and ultimately anything we can do together as a family.

In 2016 our son Fritz was diagnosed with Duchenne at just 10 months old. In the midst of wrestling with such news, and taking time to grieve the harsh reality that our life was going to look different from anything we could have ever imagined, our family started to realize that despite a muscle wasting disease; we can be strong, and Fritz can be strong, because STRENGTH IS MORE THAN MUSCLE. That phrase has become our battle cry, and we desire to share that message with the world.

One way we share our perspective of strength is through our small non-profit, Fritz&Friends. Over the past 2 years we have partnered with a variety of people and businesses to help raise funds for Duchenne Research, and we are honored to now do the same with Cure Rare Disease. We also own a Barbershop, called Fritz’s Barbershop that partners with our nonprofit to help give strength to Duchenne!

Before Duchenne entered our life, we had always preached to our kiddos; ‘teamwork makes the dream work.’ Years later, we are still finding truth in that idea. We could not be more excited to be an ambassador for Cure Rare Disease and join a team with our same dream. A dream that does not involve making a name for our self but collaborating with others. A dream that does not settle for the current process, but instead pushes to try new things. We dream of nothing short of a cure, and we are excited to a join a team that desires simply that! Strength is more than muscle, Strength is teamwork, strength is Cure Rare Disease.

Walker Penfield

Massachusetts DECA / Cure Rare Disease Liaison

Walker Penfield is a senior at Nipmuc Regional High School in Upton, Massachusetts. He serves as the Cure Rare Disease-DECA Liaison and through this position, coordinates the activities of both organizations to help advance the fight against rare diseases. Walker first learned of Cure Rare Disease and its mission through a summer internship, where he helped to establish the partnership between Massachusetts DECA and CRD. As an international organization with over 220,000 student members, DECA prepares emerging leaders and entrepreneurs for the business world through leadership conferences and competitions. Walker is a Massachusetts DECA State Officer and has competed on an international level for the past three years. As part of a project to promote financial literacy within the youth of his community, Walker developed and published an app called “Split the Difference,” which teaches students basic financial principles through a fun, visual game. This experience taught him that you can use any of your skills and passions, like programming, to have a positive impact on your community. Walker carries this mindset into his work at Cure Rare Disease and is excited to be a part of this great team.

Morgan Booher

Development Intern

Morgan Booher is a Development Intern for Cure Rare Disease. She is originally from St. Louis, MO, but has lived in Boston since 2017. She is a senior at Northeastern University, studying International Business and Marketing. At CRD, Morgan assists with development efforts including social media and graphic design. She has been with the team since September 2020, and is excited to be able to contribute to the furthering of CRD’s life saving mission.

Samhita Nittala

Development Intern

Hello, my name is Samhita! I am currently attending the University of California, Berkeley, aiming to major in Business Administration and Molecular and Cellular Biology (with a concentration of Genetics, Genomics, and Development). I seek to pursue my Ph.D. in genetics and enter into genetic therapies and personalized medicine research to usher in this new era of treatment.

Biotechnology Advisors

Carolina Alarco

Carolina Alarco currently serves as a board member for Cure Rare Disease. She has more than 25 years of experience in the biopharmaceutical industry in Cambridge, Massachusetts. Carolina has recently founded BioStrategy Advisors LLC, a strategic business consulting firm servicing small and medium-sized Biotech companies in the Massachusetts area. Specializing in biotech start-up corporate strategy, early commercial planning for assets in early-stage clinical development and commercial product launch planning for later-stage specialty therapeutics and/or orphan drugs/rare diseases.

Carolina’s passion is to bring innovative therapies for rare diseases to patients in need around the world. She has spent most of her career working in the Rare Genetic Disorders/Orphan Drugs area. Most recently, Carolina was President of Global Marketing and International Markets at Novelion Therapeutics where she lead the marketing function and the International region. Prior to this, she was President of International at Aegerion, where she built the geographical footprint of the company through innovative go-to-market strategies. Carolina was a Vice-President at Genzyme, where spent 15 years in several roles of progressive responsibility. In her tenure at Genzyme, she played a pivotal role in several product launches globally, new market development and geographical expansion.

Carolina also has a strong philanthropic focus on causes such as children in need, women in science and Latino affairs. In addition to her role at Cure Rare Disease, she has recently been appointed by Governor Baker to the Massachusetts STEM Advisory Council. She currently serves as a Founding Member and Past-Chair of the Latino Council at Boston Children’s Hospital Trust. She is co-founder and member of the Steering Committee of Latinos in Bio. She has been past-chair and Board Member of the New-England Latin America Business Council, as well as, other organizations. She holds a Bachelor of Science in Business Administration from the University of Lima (Lima, Peru) and a Graduate Degree in Business and Management from Harvard University (Cambridge, MA, USA).

Jon Bircher

Jon Bircher serves as a board member for Cure Rare Disease and provides a footprint for us in Europe. Jon has worked in the health and biopharmaceutical industry for more than 20 years and as Chief Commercial Officer and board director at Cello Health is responsible for supporting business growth through sales, marketing, innovation and strategic partnerships. Cello Health is a global strategic advisory firm with deep experience and relevant expertise in science, insights, strategy and commercial.

Jon loves combining his leadership, critical thinking and strategic planning skills to tackle the industry’s most difficult commercial challenge. Over the years he has worked across multiple therapy areas and geographies with a focus on helping companies bring new therapies to the patients that need them. In his board role Jon looks forward to applying these skills and experiences to advancing the cutting-edge work of CRD in developing customized therapeutics at unparalleled speed, starting with DMD.

Jamie Heywood

ALS Therapy Development Institute & Patients Like Me

An MIT-trained mechanical engineer, Jamie entered the field of translational medicine when his 29 year old brother Stephen was diagnosed with ALS, or Lou Gehrig’s Disease. Described by CNNMoney as one of the 15 companies that will change the world, Jamie co-founded PatientsLikeMe to ensure patient outcomes become the primary driver of the medical care and discovery process. Jamie is also the founder and past CEO of the ALS Therapy Development Institute (ALS TDI), the world’s first non-profit biotechnology company. During his tenure at ALS TDI, Jamie helped pioneer an open research model and industrialized therapeutic validation process that made ALS TDI the world’s largest and most comprehensive ALS research program. Jamie has founded or co-founded three other health care companies: AOBiome, Genetic Networks, and TheSocialMedwork, and is an active member of a community of innovators working to bring dramatic improvements to the way we discover, develop and deliver effective health. Jamie and his brother were the subject of Pulitzer Prize-winning author Jonathan Weiner’s biography His Brother’s Keeper and the documentary So Much So Fast.

Jonathan Fleming

QurAlis

Jonathan J. Fleming is President and CEO of Q-State Biosciences, and early stage private funded neuroscience company in Cambridge MA. Q-State uses its proprietary technology platform to enable the discovery of new medicines for diseases such as ALS, epilepsy, Parkinson’s Disease and neuropathic pain. Prior to Q State Mr. Fleming was President of NEHI (Network for Excellence in Health Innovation) a nonprofit, non-partisan health policy institute focused on enabling innovations that improve the quality and lower the costs of health care. Since 1999, Mr. Fleming has been the Managing Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science investments, based in Boston, MA. Mr. Fleming has been in the investment business for more than 31 years, starting and financing growth companies in the United States, Europe, Israel and Asia. Prior to joining Oxford Bioscience Partners in 1996, he was a Founding General Partner of MVP Ventures in Boston, MA. He began his investment career with TVM Techno Venture Management in Munich, Germany. Mr. Fleming also co-founded Medica Venture Partners, a venture capital investment firm specializing in early stage health care and biotechnology companies in Israel, and the Korea Seoul Life Science Fund, based in Seoul, Korea. He is also a director of Leerink Partners, a Boston based investment bank specializing in health care companies. In addition, Mr. Fleming has been a Senior Lecturer at the MIT Sloan School of Management since 2002, where he co-teaches a class on business strategy for life science managers. Mr. Fleming holds a Master’s degree in Public Administration from Princeton University’s Woodrow Wilson School of Public and International Affairs, and a Bachelor’s degree in Political Science from the University of California, Berkeley.

Esports Advisory Board

Esports provide differently-abled individuals an escape from reality and acts as an equalizer to their able-bodied peers. Christian Bishop, Chief Revenue Officer at Method, leads our esports development effort. We have established the Cure Rare Disease Esports Advisory Board, an elite group of individuals who are well-connected and respected in the esports space. The purpose of this board is to increase awareness of our mission and fundraising capacity to develop customized therapeutics. Keep up to date with CRD’s esports efforts by following @CRDGame4Good on Twitter.

Christian Bishop

Chief Revenue Officer, METHOD

As the previous World Showdown of Esports (WSOE) Commissioner, Christian Bishop was an integral part of the multi-genre, multi-game tournament series development since joining the team in Fall 2018.

Today, Bishop is now responsible for the sales and partnership team as Chief Revenue Officer, while managing current and new developer partnerships. He also oversees new, large-scale business opportunities and transactions to accelerate Method’s global growth strategy.

Christian Bishop also served as the Director of Gaming at Thunder Gaming, the largest esports gaming and production center in the West Coast with a total property size of 150,000 square feet. Over the course of his career, Bishop has served as an Enterprise Media Director with Level 3 Communications, AT&T and Time Warner Inc. In addition, he served as a Director of Content for BidChat, a cutting edge two-way live broadcasting platform for social influencers.

In 2017, Bishop also launched “4Cast,” the first of its kind esports and gaming show to deliver unique esports and gaming news and information in an entertaining and engaging format that appeals to all gamers and fans. He is also an Executive Producer for the film “Huntsville” and is most recognized from his recent work on ABC’s “The Bachelorette” and “Bachelor in Paradise.”

Bishop also serves on several boards and participates in community organizations such as the Western Regional Diversity Council, where he works to advance and sustain an inclusive environment for gaming enthusiasts. He earned a bachelor’s degree in business from California State University, Northridge.

Justin Dellario

Head of Esports, Twitch

Justin Dellario is the Head of Twitch Esports, where he oversees competitive gaming operations for the world’s largest video game live streaming platform. Justin works with game developers, tournament organizers, professional teams, and broadcasters to direct the business, strategy, and operation of esports leagues, tournaments, and circuits globally. Prior to Twitch, Justin served as Head of Global Esports for gaming hardware developer, Razer, where he developed the company’s sponsorship and marketing campaigns.

Sundance Giovanni

Co-Founder and CEO, Major League Gaming

Sundance DiGiovanni is a seasoned executive, recognized thought leader in video game culture, and veteran creative director with more than 18 years of experience in the media, technology and video game space.

Sundance currently serves as CEO of Major League Gaming (MLG), now the world’s largest competitive video game league and provider of cross platform online videogame competition. Sundance co-founded MLG in 2002 with longtime friend Mike Sepso to combine his lifelong passion for gaming with his deeply competitive nature. As CEO, Sundance focuses on the long-term, global growth of competitive video gaming and the various distribution channels that are helping to bring this burgeoning sport to an ever-growing community worldwide.

MLG reaches millions of consumers each month at www.majorleaguegaming.com and holds more than 750,000 matches online at www.gamebattles.com. MLG also operates the annual Pro Circuit of video game competitions – in person events where the world’s best gamers compete. All Pro Circuit play is broadcast via LIVE streaming online to hundreds of thousands of fans from more than 170 countries. MLG enables a large and growing community and a roster of top sponsors to connect with and celebrate the tens of millions of consumers worldwide who have a passion for playing video games as a competitive social activity.

Sundance has become one of the world’s leading experts on gaming culture making regular appearances as an on-air video game lifestyle commentator on an array of networks. He previously served as ESPN’s first and only gaming correspondent for ESPN 2’s Cold Pizza.

Prior to co-founding MLG, Sundance was the Worldwide Creative Director of Gotham Broadband, a New York based digital consultancy. Gotham Broadband’s primary business was developing broadband strategies, consumer services and business models for some of the largest traditional media and cable and telco companies in the world.

As a creative director, he has worked with a wide range of brands including AOL Time Warner, DirecTV, Sony, Pfizer, Nortel Networks, and Sprint.

Sundance attended NYU’s Tisch School of the Arts for Film. He currently lives in New York.

John Benyamine

EVP of Business Development, ReKTGlobal

John Benyamine is the EVP of Business Development at ReKTGlobal, a global esports business authority and parent company of professional esports organizations Rogue and the London Royal Ravens. He helped in ReKTGlobal’s 2020 acquisition of New York City-based media agency Fearless Media, and continues to identify new business opportunities for the conglomerate.

John is also a proud co-owner of Shacknews.com, one of gaming’s biggest independent publications reaching millions of readers every month, and Retronauts.com, a popular and prestigious retro gaming podcast. He previously served as co-founder and CEO of Greenlit Content, a content marketing agency focused on the video game and esports industries, which was acquired by ReKTGlobal in 2019. Greenlit efforts have been responsible for number one streams on Twitch, YouTube Gaming, and Facebook Gaming in 2020, featuring musicians, athletes, and celebrities in a variety of fun gaming-related shows.

Prior to that, John led the US business for Gamer Network, creator of publications including Eurogamer, USgamer, and Digital Foundry. He also created and sold IndustryGamers, a prestigious video game business publication, and GameDaily, a popular consumer gaming site that eventually merged into Joystiq and Engadget following its acquisition by AOL.

John holds an M.A. in Corporate Communication from Fairleigh Dickinson University, and a B.A. in Communication and New Media from Rutgers College, Rutgers University. Born in Brooklyn and based in northern New Jersey, John is a proud first generation American, an avid gamer, a devoted husband, and father of two amazing daughters.

Harris Peskin

Partner, ESG Law

Throughout his career Harris has continuously sought to elevate legal academia, improve industry standard, and create a more sustainable economic foundation for esports teams and ancillary businesses. Harris is an attorney at ESG Law, the world’s first esports specific law firm, where he represents roughly 70% of all tier 1 North American and European esports teams, as well as their non-endemic professional sports partners. At the esports league level, Harris has played a crucial role in redefining team governance and revenue sharing rights, having played a leading role in LCS, LEC, OWL and CDL league-team negotiations since 2016. Harris has drafted and negotiated several of the most notable team sponsorship deals with endemic and non-endemic partners such as PUMA, BMW, AT&T, Logitech, and Dr. Pepper, among others. In 2017 Harris revolutionized LCS team-legal strategies when he became the first attorney to file an EB-1A (US Green Card) application on behalf of an esports player and in turn helped that player acquire US residency so as to avoid being counted as a foreign import against Riot’s team foreign import cap.

Since the start of 2018 Harris has led the esports academic community serving as Executive Director and Chairman of the Publications, Public Policy, and Membership Committees of the Esports Bar Association. Today the EBA has: over 200 attorney and student members, organized three esports legal conferences, distributed the first ever esports legal academic journal, and advised state legislatures on policies that will affect the esports business landscape. The EBA is primed to become a leading esports policy and academic organization in the United States. Harris is an adjunct professor at the University of New Hampshire School of Law where he lectures on esports gambling legal issues.

In 2016 Harris brokered the acquisition of H2K Gaming on behalf of US based investors. At the time, the acquisition was one of the largest in European esports history. After brokering the acquisition, Harris served as Chief of Operations and Associate General Counsel for H2K Gaming where he helped to assemble the famed H2K squad that finished third in the world at the 2016 League of Legends World Championships.

Chris Mann

Chief Operating Officer, Subnation

COO of Subnation, Chris has been a gamer, technophile and early adopter since his formative years. For the past 15 years, Chris has served major corporations and start-ups in roles focusing on global branding, sales, marketing, business development and strategy. Chris is a regular speaker and participant at gaming and esports industry events, including initiatives that focus on commercialization, convergence and interoperability of products, technology and marketing.

Brandon Bagley

Partner, C4+

Brandon is a partner at C4+, a holdings company and investment firm focused on start-ups across esports and gaming. Prior to C4+, Brandon served as COO of VY Esports, a global esports media company based out of Los Angeles and backed by Warner Music Group and The Raine Group.

Brandon was also formerly VP of Operations for the Texas Rangers-backed Infinite Esports & Entertainment (which was acquired by Immortals Gaming Club), which included Call of Duty giant OpTic Gaming as well as franchise spots in the Overwatch League (OWL) and League of Legends Championship Series (LCS).

Brandon graduated from the Wharton School at the University of Pennsylvania. In his free time he is an avid soccer player, skier, traveler, and proud Bernese Mountain Dog dad.